Lindbrook Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $236K | Buy |
562
+274
| +95% | +$115K | 0.02% | 364 |
|
|
2024
Q4 | $119K | Sell |
288
-53
| -16% | -$21.9K | 0.01% | 510 |
|
|
2024
Q3 | $172K | Buy |
341
+15
| +5% | +$7.58K | 0.02% | 425 |
|
|
2024
Q2 | $159K | Buy |
326
+18
| +6% | +$8.77K | 0.01% | 410 |
|
|
2024
Q1 | $166K | Buy |
308
+5
| +2% | +$2.7K | 0.02% | 397 |
|
|
2023
Q4 | $168K | Buy |
303
+55
| +22% | +$30.5K | 0.02% | 380 |
|
|
2023
Q3 | $108K | Sell |
248
-45
| -15% | -$19.7K | 0.01% | 444 |
|
|
2023
Q2 | $147K | Buy |
293
+51
| +21% | +$25.6K | 0.02% | 395 |
|
|
2023
Q1 | $121K | Buy |
242
+107
| +79% | +$53.5K | 0.01% | 433 |
|
|
2022
Q4 | $55.1K | Buy |
135
+78
| +137% | +$31.8K | 0.01% | 663 |
|
|
2022
Q3 | $19K | Buy |
57
+12
| +27% | +$4K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $16K | Buy |
45
+6
| +15% | +$2.13K | ﹤0.01% | 1061 |
|
|
2022
Q1 | $21K | Sell |
39
-18
| -32% | -$9.69K | ﹤0.01% | 985 |
|
|
2021
Q4 | $38K | Buy |
57
+11
| +24% | +$7.33K | 0.01% | 810 |
|
|
2021
Q3 | $29K | Buy |
46
+4
| +10% | +$2.52K | 0.01% | 612 |
|
|
2021
Q2 | $27K | Sell |
42
-10
| -19% | -$6.43K | 0.01% | 670 |
|
|
2021
Q1 | $25K | Buy |
52
+22
| +73% | +$10.6K | 0.01% | 668 |
|
|
2020
Q4 | $15K | Buy |
30
+12
| +67% | +$6K | ﹤0.01% | 771 |
|
|
2020
Q3 | $7K | Sell |
18
-81
| -82% | -$31.5K | ﹤0.01% | 962 |
|
|
2020
Q2 | $33K | Sell |
99
-7
| -7% | -$2.33K | 0.01% | 464 |
|
|
2020
Q1 | $26K | Buy |
106
+16
| +18% | +$3.93K | 0.01% | 468 |
|
|
2019
Q4 | $24K | Buy |
90
+11
| +14% | +$2.93K | 0.01% | 671 |
|
|
2019
Q3 | $21K | Sell |
79
-8
| -9% | -$2.13K | 0.01% | 693 |
|
|
2019
Q2 | $23K | Buy |
87
+8
| +10% | +$2.12K | 0.01% | 645 |
|
|
2019
Q1 | $17K | Buy |
79
+75
| +1,875% | +$16.1K | 0.01% | 747 |
|
|
2018
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1395 |
|